Upstream Bio (UPB) Receivables - Net (2023 - 2026)

Upstream Bio's (UPB) quarterly Receivables - Net came in at $1.0 million in Q1 2026, up 82.69% year-on-year from $566000.0 in Q1 2025, and up 54.79% quarter-over-quarter from $668000.0 in Q4 2025.

Upstream Bio (UPB) Receivables - Net (2023 - 2026) Analysis & Trends

Upstream Bio's Receivables - Net history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 82.69% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 82.69% increase from a year earlier, with the FY2025 full-year figure at $668000.0, up 8.97% from the prior year.
  • Receivables - Net rose to $1.0 million in Q1 2026 per UPB's latest filing, from $668000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.0 million in Q1 2026 and bottomed at $98000.0 in Q4 2023.
  • The 4-year median for Receivables - Net is $613000.0 (2024), against an average of $611777.8.
  • Across the five-year window, Receivables - Net soared 525.51% in 2024 and rose 8.97% in 2025, its largest moves.
  • Year by year, Receivables - Net stood at $98000.0 in 2023, then surged by 525.51% to $613000.0 in 2024, then grew by 8.97% to $668000.0 in 2025, then jumped by 54.79% to $1.0 million in 2026.
  • Per Business Quant, the three latest UPB Receivables - Net figures stand at $1.0 million (Q1 2026), $668000.0 (Q4 2025), and $683000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Upstream Bio 347.73 Mn 347.73 Mn -3.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 668,000.00
Dec 31, 2025 668,000.00
Sep 30, 2025 683,000.00
Sep 30, 2025 683,000.00
Jun 30, 2025 937,000.00
Jun 30, 2025 937,000.00
Mar 31, 2025 566,000.00
Mar 31, 2025 566,000.00
Dec 31, 2024 613,000.00
Dec 31, 2024 613,000.00
Sep 30, 2024 607,000.00
Sep 30, 2024 607,000.00
Dec 31, 2023 98,000.00
Dec 31, 2023 98,000.00
Sep 30, 2023 300,000.00
Sep 30, 2023 300,000.00